A new drug to treat ovarian cancer just got approved (CLVS)
|12/19/2016||Posted by BusinessMediaguide.Com under General World News||
The FDA just approved a new ovarian cancer drug.
The drug, called Rubraca, is approved to treat women with advanced ovarian cancer who have been treated with two or more chemotherapies and whose tumors have a specific gene mutation. That gene mutation, deleterious BRCA, will have to be identified via a genetic test that the FDA approved Monday.
Clovis Oncology, the drugmaker behind Rubraca, was up as much as 15% following news of the approval.